{"id":91780,"topic":"peptides","source":"kalkine.ca","title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","url_hash":"a9073d6ddd6e83f1fecd2a6ad7486d0e362f18c0","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5\" target=\"_blank\">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">kalkine.ca</font>","content":null,"image_url":null,"lang":"en","published_at":"2026-09-28T08:25:00+00:00","fetched_at":"2026-09-28T09:15:10+00:00","status":"read","starred":0,"extract_state":"failed","summary_auto":null,"cluster_id":null,"extract_retries":2,"extract_error":"http_403","contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":608,"usable_text_length":608,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":608}},"news_item":{"id":91780,"canonical_url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","source_url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","source_name":"kalkine.ca","author":null,"published_at":"2026-09-28T08:25:00+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5\" target=\"_blank\">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">kalkine.ca</font>","full_text":null,"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5\" target=\"_blank\">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">kalkine.ca</font>","extraction":{"state":"failed","confidence":0.0,"error":"http_403","explanation":"Low confidence: HTTP extraction failure (http_403).","diagnostics_url":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":608,"usable_text_length":608,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":608}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","summary":"<a href=\"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5\" target=\"_blank\">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">kalkine.ca</font>","source":"kalkine.ca","date":"2026-09-28T08:25:00+00:00","content":"","confidence":0.0,"diagnostics_url":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","quality_bucket":"failed","failure_kind":"http","retryable":false,"quality_reason":"Low confidence: HTTP extraction failure (http_403).","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":608,"usable_text_length":608,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":608}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/91780","export_markdown":"/api/items/91780/export?format=markdown","export_json":"/api/items/91780/export?format=json","diagnose":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment"},"formats":{"full":{"id":91780,"title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","source":"kalkine.ca","author":null,"published_at":"2026-09-28T08:25:00+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5\" target=\"_blank\">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">kalkine.ca</font>","full_text":null,"reading_time_min":1,"extraction":{"state":"failed","confidence":0.0,"error":"http_403","explanation":"Low confidence: HTTP extraction failure (http_403).","diagnostics_url":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":608,"usable_text_length":608,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":608}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":608,"usable_text_length":608,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":608}},"actions":{"read":"/item/91780","export_markdown":"/api/items/91780/export?format=markdown","export_json":"/api/items/91780/export?format=json","diagnose":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment"}},"digest":{"id":91780,"title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","source":"kalkine.ca","topic":"peptides","published_at":"2026-09-28T08:25:00+00:00","excerpt":"<a…","quality_bucket":"failed","quality_reason":"Low confidence: HTTP extraction failure (http_403).","reading_time_min":1,"cluster_id":null},"card":{"display_title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","subtitle":"kalkine.ca · 2026-09-28","summary":"<a…","badges":["quality:failed","issue:http"],"links":{"read":"/item/91780","original":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","diagnose":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment"},"quality_warning":"Low confidence: HTTP extraction failure (http_403)."},"export":{"title":"Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca","url":"https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","summary":"<a href=\"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5\" target=\"_blank\">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">kalkine.ca</font>","source":"kalkine.ca","date":"2026-09-28T08:25:00+00:00","content":"","confidence":0.0,"diagnostics_url":"/api/diagnose?url=https%3A//kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment","quality_bucket":"failed","failure_kind":"http","retryable":false,"quality_reason":"Low confidence: HTTP extraction failure (http_403).","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"failed","confidence":0.0,"failure_kind":"http","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: HTTP extraction failure (http_403).","operator_guidance":{"severity":"action_required","recommended_action":"manual_review","next_step":"Open diagnostics and review the original source manually before use.","operator_label":"Manual review","can_retry":false,"can_use_summary":false,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":608,"usable_text_length":608,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"http_403","extract_retries":2,"content_length":0,"summary_length":608}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}